-
公开(公告)号:US20200040103A1
公开(公告)日:2020-02-06
申请号:US16352619
申请日:2019-03-13
Applicant: Genentech, Inc.
Inventor: Cecilia P. C. Chiu , Hilda Y. Hernandez-Barry , David B. Iaea , Moulay Hicham Alaoui-Ismaili , James T. Koerber , Wei Yu Lin , Kelly Loyet , Yonglian Sun , Benjamin T. Walters , Jawahar Sudhamsu
Abstract: The invention provides anti-KLK5 antibodies and methods of using the same.
-
公开(公告)号:US12037412B2
公开(公告)日:2024-07-16
申请号:US16950418
申请日:2020-11-17
Applicant: Genentech, Inc.
Inventor: Cecilia P. C. Chiu , Hilda Y. Hernandez-Barry , David B. Iaea , Moulay Hicham Alaoui-Ismaili , James T. Koerber , Wei Yu Lin , Kelly Loyet , Yonglian Sun , Benjamin T. Walters , Jawahar Sudhamsu
CPC classification number: C07K16/40 , A61K47/6871 , C07K2317/24 , C07K2317/34 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides anti-kallikrein-related peptidase 5 (KLK5) antibodies and methods of using the same.
-
公开(公告)号:US20190078160A1
公开(公告)日:2019-03-14
申请号:US15958696
申请日:2018-04-20
Applicant: Genentech, Inc.
Inventor: Amy Dressen , David B. Iaea , Moulay Hicham Alaoui Ismaili , Janet K. Jackman , Robert A. Lazarus , Kelly Loyet , Henry R. Maun , Brian L. Yaspan , Tangsheng Yi , Joseph R. Arron , Hilda Y. Hernandez-Barry
IPC: C12Q1/6883
Abstract: Provided herein are methods of treating a subject, methods of predicting the response of a subject and selecting a subject suffering from a disease associated with KLK5, such as asthma or Netherton Syndrome. In particular, provided herein are uses of KLK5 antagonists for the treatment or diagnosis of asthma or Netherton Syndrome, such as an antibody or an Fc fusion polypeptide as well as pharmaceutical formulations comprising the same.
-
公开(公告)号:US20210301032A1
公开(公告)日:2021-09-30
申请号:US16950418
申请日:2020-11-17
Applicant: Genentech, Inc.
Inventor: Cecilia P.C. Chiu , Hilda Y. Hernandez-Barry , David B. Iaea , Moulay Hicham Alaoui-Ismaili , James T. Koerber , Wei Yu Lin , Kelly Loyet , Yonglian Sun , Benjamin T. Walters , Jawahar Sudhamsu
Abstract: The invention provides anti-KLK5 antibodies and methods of using the same.
-
-
-